H+H International A/S
25.3.2021 08:14:19 CET | Globenewswire | Press release
In 4 March 2021, H+H International A/S (hereinafter referred to as "H+H" or "the Company") initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the "Safe Harbour Regulation"). On 18 March 2021, the share buy-back programme was increased by DKK 15 million, thereby increasing the maximum aggregate purchase price of the shares to be bought back under the programme to DKK 115 million.
The share buy-back programme is expected to be realised over a 12-month period, starting from 4 March 2021. Under the share buy-back programme, H+H may repurchase shares up to a maximum amount of DKK 115 million, and no more than 1,728,136 shares, corresponding to approximately 9.6 percent of the share capital of the Company.
The following transactions were executed under the share buy-back programme from 17 March 2021 to 23 March 2021:
| No. of shares | Average price (DKK) | Total value (DKK) | |
| Accumulated, last announcement | 40,500 | 6,146,902.00 | |
| 17 March 2021 | 4,000 | 149.69 | 598,760.00 |
| 18 March 2021 | 6,000 | 150.06 | 900,360.00 |
| 19 March 2021 | 6,000 | 150.44 | 902,640.00 |
| 22 March 2021 | 6,000 | 152.08 | 912,480.00 |
| 23 March 2021 | 5,000 | 154.15 | 770,750.00 |
| Total | 27,000 | 4,084,990.00 | |
| Accumulated under the programme | 67,500 | 10,231,892.00 |
Details of each transaction are included as an appendix to this announcement.
Following these transactions, H+H holds 137,700 shares as treasury shares, corresponding to 0.77 percent of the Company’s total share capital.
For further information please contact:
Andreas Holkjær
Investor Relations and Treasury Manager
+45 24 48 03 67
aho@HplusH.com
Attachments
- 411 - Transactions in connection with share buy-back programme
- 411 - Appendix - Specification - 17.03.2021 to 23.03.2021
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Alkane Resources Limited30.3.2026 00:16:17 CEST | Press release
Alkane Executes $110 Million Revolving Credit Facility
Fast Ejendom Danmark29.3.2026 18:17:55 CEST | Pressemeddelelse
Aktietilbagekøbsprogram
Newcap Holdings29.3.2026 12:19:20 CEST | Pressemeddelelse
NewCap Holding A/S har indgået en aftale, betinget af underskrivelse af endelige aftaledokumenter m.v., om erhvervelse af dansk selskab indenfor compliance og risikostyringsservices – Intern viden
Novartis Pharma AG29.3.2026 07:15:00 CEST | Press release
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
Biogen Inc.28.3.2026 20:00:00 CET | Press release
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
